The macroeconomic backdrop for "onph stock forecast 2025" improves under a stable interest rate environment. A dovish Fed stance historically favors biotech valuations, potentially adding 15–18% to sector P/S ratios. Jun 12, 2025 · ONCOLOGY PHARMA INC (ONPH) stock price prediction until 12 Dec 2025 (update date: 12 Jun 2025 ) Forecast until 12 Dec 2025 shows that the price will grow by 0% probability and have a downward trend by 0.4% probability. Innovative healthcare stocks are also a good bet to make investors richer over time. Telehealth kingpin Teladoc Health (NYSE: TDOC) is one such company that has the capacity to turn a $50,000 investment into a cool $1 million in under two decades. Institutional coverage on "onph stock forecast 2025" notes that a favorable macro outlook and increased R&D spending could support long-term valuation. Current P/E remains negative, but revenue from licensing deals may re-rate the stock closer to 2.5x forward sales by late 2025.